Valuation: LeMaitre Vascular, Inc.

Market Cap 1.86B 1.66B 1.53B 1.39B 2.6B 176B 2.67B 18.19B 7.32B 92.91B 6.97B 6.83B 295B P/E 2026 *
28.3x
P/E 2027 * 25.6x
Enterprise Value 1.62B 1.45B 1.33B 1.21B 2.27B 153B 2.32B 15.83B 6.37B 80.89B 6.07B 5.94B 257B EV / Sales 2026 *
5.85x
EV / Sales 2027 * 5.14x
Free-Float
87.26%
Yield 2026 *
1.23%
Yield 2027 * 1.38%
1 day-0.81%
1 week-4.40%
Current month-0.42%
1 month+2.08%
3 months-20.45%
6 months-28.06%
Current year-0.62%
1 week 80.03
Extreme 80.03
85.65
1 month 78.31
Extreme 78.31
85.81
Current year 78.22
Extreme 78.22
118.01
1 year 78.22
Extreme 78.22
118.01
3 years 47.72
Extreme 47.72
118.01
5 years 38.32
Extreme 38.32
118.01
10 years 18.76
Extreme 18.76
118.01
Manager TitleAgeSince
Chief Executive Officer 61 31/05/1992
Director of Finance/CFO 51 09/03/2025
Director of Finance/CFO 62 31/12/1999
Director TitleAgeSince
Director/Board Member 68 31/12/2002
Chairman 61 31/12/2003
Director/Board Member 61 23/10/2016
Date Insider Type Main position Quantity % Market Cap. Importance
03/09/26 Free

Chairperson

24 0.0001%
03/09/26 Free

Director

6 0.0000%
03/09/26 Free

Chief Operating Officer

14 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.81%-4.40%-6.94%+72.78% 1.86B
+2.30%+1.96%+23.08%+56.03% 253B
+0.94%-1.23%+6.84%+19.24% 160B
+0.89%-2.41%-17.51%+58.61% 151B
-1.85%-4.56%-56.81%-17.17% 64.23B
-0.12%+2.51%-10.75%-8.53% 54.11B
+2.07%+5.11%+15.45%+45.26% 53.76B
-1.23%-4.70%+4.12%+59.66% 49.71B
+2.02%-0.28%+19.88%+67.95% 48.49B
+2.31%+0.86%+31.55%+87.40% 44.17B
Average +0.50%-1.05%+0.89%+44.12% 88.11B
Weighted average by Cap. +0.86%-0.76%+3.90%+42.29%

Financials

2026 *2027 *
Net sales 277M 247M 227M 206M 388M 26.2B 397M 2.71B 1.09B 13.83B 1.04B 1.02B 43.89B 303M 271M 249M 226M 425M 28.7B 435M 2.96B 1.19B 15.15B 1.14B 1.11B 48.08B
Net income 66.71M 59.63M 54.78M 49.75M 93.49M 6.32B 95.82M 653M 263M 3.34B 250M 245M 10.59B 74.29M 66.4M 60.99M 55.4M 104M 7.04B 107M 727M 293M 3.71B 279M 273M 11.79B
Net Debt -240M -215M -197M -179M -337M -22.78B -345M -2.35B -947M -12.02B -903M -883M -38.17B -300M -269M -247M -224M -421M -28.46B -431M -2.94B -1.18B -15.02B -1.13B -1.1B -47.68B
Projected Income Statement - Annual - LeMaitre Vascular, Inc.
Logo LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. It develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which are used in open vascular surgery and dialysis access. It offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold globally in the United States, Europe, Canada and Asia Pacific.
Employees
651
Date Price Change Volume
03/11/26 US$80.60 -0.81% 373,008
02/11/26 US$81.26 +0.40% 270,729
30/10/26 US$80.94 -5.08% 427,366
29/10/26 US$85.27 +2.90% 300,113
28/10/26 US$82.87 -1.10% 360,738
Trader
Investor
Global
Quality
ESG MSCI
CCC
MarketScreener Ratings - LeMaitre Vascular, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
81.26USD
Average target price
107.00USD
Spread / Average Target
+31.68%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - LeMaitre Vascular, Inc.
  1. Stock Market
  2. Stocks
  3. LMAT Stock